| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_313a5f9e3decaee61deaaaa1c737390c |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D513-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D513-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 |
| filingDate |
2001-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2003-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7d9787a53719cbb33e4be5a62f9e2449
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a0e1069f041d18d8778bc2df5bce1c72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9316663aa4850b492f2262fbb0314d13 |
| publicationDate |
2003-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-6656940-B2 |
| titleOfInvention |
Tricyclic quinoxaline derivatives as protein tyrosine kinase inhibitors |
| abstract |
The present invention relates to tricyclic quinoxaline compounds and physiologically acceptable salts and prodrugs thereof which modulate the activity of protein tyrosine kinases and therefore should be useful in the prevention and treatment of protein tyrosine kinase related cellular disorders such as cancer. |
| priorityDate |
1997-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |